RaySearch Laboratories AB (publ) Interim Report January 1 - September 30, 2004

• Net sales totaled SEK 29.0m (24.9) between January and September 2004 • Net profit was SEK 11.3m (7.4) during the period • Earnings per share after tax reached SEK 1.08 (0.70) • Operating profit totaled SEK 12.9m (11.4) • Investments in research and development increased by 60 percent • New products based on the partnership with both Philips which Nucletron have been well received at significant industry meetings • First OM-Optimizer order received For more information, please contact: Johan Löf CEO, RaySearch Laboratories AB Phone: +46 (0)8-545 061 30 johan.lof@raysearchlabs.com

About Us

RaySearch Laboratories AB (publ) has been pushing the limits of advanced cancer treatment since 2000. Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world. The algorithms are based upon founder and CEO Johan Löf’s scientific knowledge, acquired during his PhD on radiation treatment of moving tumors at the Karolinska Institute. The treatment planning system RayStation and the OIS RayCare are the result of extensive development during years of research, and today used to improve chances of survival and quality of life for cancer patients. We fight for a world where cancer is conquered.


Documents & Links